Considering that AMPK is already a targetable candidate in peripheral tissues to treat insulin resistance (metformin) (Zhou et al., 2001), the relationship with BMP8B could offer new opportunities for drug design. The gene discussed is PRKAA1; the disease is Insulin resistance.